Moreover, a strong and independent correlation between high GR expression and poor clinical outcomes was recently found by our group in a cohort of 12,152 prostate cancer samples by using the same IHC assay as in this study (Heckmann et al., submitted). The gene discussed is NR3C1; the disease is prostate cancer.